|
⚲
|
| Keyboard |
| Michael Rome | |
|---|---|
| Firm | |
| Address | 240 Via Las Brisas Palm Beach, FL 33480 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Remix Therapeutics Inc | 021-501562 | Director | 13.7 M of 90.0 M |
||
| Avenzo Therapeutics Inc | 021-460216 | Director | 385.9 M of 385.9 M |
||
| FL2021-001 Inc | 021-392889 | Director | 60.0 M of 60.0 M |
||
| Theseus Pharmaceuticals Inc | 021-388439 | Director | 95.1 M of 100.1 M |
||
| Kinnate Biopharma Inc | 021-372487 | Director | 98.0 M of 98.0 M |
||
| Kinnate Biopharma Inc | 021-356223 | Director | 74.5 M of 74.5 M |
||
| Theseus Pharmaceuticals Inc | 021-315789 | Director | 22.1 M of 22.1 M |
||
| Rome Capital Investors Offshore Ltd | 021-303285 | Director | 6.4 M | ||
| Seaview Capital Partners LP | 021-209748 | Executive Officer | 34.2 M | ||
| Seaview Offshore Fund Ltd | 021-209750 | Executive Officer | 5.0 M | ||